One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups

Japanese Journal of Ophthalmology

Volumn 53, Issue 4, 2009, Pages 389-395

  Kang, Seungbum ^a   Roh, Young Jung ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Neovascular age related macular degeneration; Ranibizumab; Subgroup analysis

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; STATISTICAL SIGNIFICANCE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINA; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 70349308115     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-009-0670-y     Document Type: Article

References (22)

1. F.L. Ferris S.L. Fine L. Hyman 1984 Age-related macular degeneration and blindness due to neovascular maculopathy Arch Ophthalmol 107 1640 1642
2. R.N. Frank R.H. Amin D. Eliott J.E. Puklin G.W. Abrams 1996 Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes Am J Ophthalmol 122 393 403
3. A. Kvanta P.V. Algvere L. Berglin S. Seregard 1996 Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor Invest Ophthalmol Vis Sci 37 1929 1934
4. J.M. Rakic V. Lambert L. Devy 2003 Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization Invest Ophthalmol Vis Sci 44 3186 3193
5. A.P. Adamis D.T. Shima 2005 The role of vascular endothelial growth factor in ocular health and disease Retina 25 111 118
6. E.W. Ng A.P. Adamis 2005 Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration Can J Ophthalmol 40 352 368
7. P.K. Kaiser D.M. Brown K. Zhang 2007 Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results Am J Ophthalmol 144 850 857
8. E.S. Gragoudas A.P. Adamis E.T. Cunningham 2004 Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 2805 2816
9. C.A. Cleary S. Jungkim K. Ravikumar 2008 Intravitreal bevacizumab in the treatment of neovascular age-related macular degeneration, 6 and 9 month results Eye 22 82 86
10. P.J. Rosenfeld D.M. Brown J.S. Heier 2006 Ranibizumab for neovascular age-related macular degeneration N Eng J Med 355 1419 1431
11. D.M. Brown P.K. Kaiser M. Michels 2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Eng J Med 355 1432 1444
12. A.E. Fung G.A. Lalwani P.J. Rosenfeld 2007 An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration Am J Ophthalmol 143 566 583
13. Z.F. Bashshur Z.A. Haddad A. Schakal 2008 Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study Am J Ophthalmol 145 249 256
14. D.S. Boyer A.N. Antoszyk C.C. Awh 2007 Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration Ophthalmology 114 246 252
15. S.H. Byeon S.C. Lee H.S. Oh 2008 Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients Jpn J Ophthalmol 52 57 62
16. I. Maruko T. Iida M. Saito 2007 Clinical characteristics of exudative age-related macular degeneration in Japanese patients Am J Ophthalmol 144 15 22
17. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy Study Group Verteporfin in Photodynamic Therapy Study Group. 2003 Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to agerelated macular degeneration: TAP and VIP report no. 1 Am J Ophthalmol 136 407 418
18. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy 1999 Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report Arch Ophthalmol 117 1329 1345
19. S. Fraser-Bell J. Wu R. Klein 2008 Cardiovascular risk factors and age-related macular degeneration: the Los Angeles Latino Eye Study Am J Ophthalmol 145 308 316
20. J.S. Tan P. Mitchell W. Smith J.J. Wang 2007 Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study Ophthalmology 114 1143 1150 (Pubitemid 46829381)
21. R. Klein B.E. Klein S.C. Tomany K.J. Cruickshanks 2003 The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study Ophthalmology 110 636 643 (Pubitemid 36520056)
22. C.D. Regillo D.M. Brown P. Abraham 2008 Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1 Am J Ophthalmol 145 239 248